Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ching-Yuan Cheng

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Cancer Chemotherapy and Pharmacology|February 5, 2013
Reply to: Clusterin inhibition to enhance tumor chemosensitivity in systemic tumorsChing-Yuan Cheng, Shur-Hueih Cherng, Wen-Jun Wu, et al.
Cancer Chemotherapy and Pharmacology|June 2, 2011
Regulation of chemosensitivity and migration by clusterin in non-small cell lung cancer cellsChing-Yuan Cheng, Shur-Hueih Cherng, Wen-Jun Wu, et al.
Biochemical Pharmacology|June 25, 2026
WISP-3 drives LUAD metastasis by suppressing miR-5004-5p to upregulate MMP-12Chia-Chia Chao, Chiang-Wen Lee, Syuan-Ling Lin, et al.
Scientific Reports|April 22, 2025
Comparison of outcome between sole operation and operation after tube thoracostomy in late phase empyemaShao-Syuan Tong, Yi-Ling Chen, Ya-Fu Cheng, et al.
Cancer Chemotherapy and Pharmacology|January 10, 2025
Endoglin as a predictive biomarker for pemetrexed sensitivity in non-small-cell lung cancer: a cellular studyChing-Yuan Cheng, Wen-Chen Chuang, Ching-Pin Lin, et al.
Plos One|October 13, 2022
Propensity score analysis comparing survival between definitive chemoradiotherapy and esophagectomy with adjuvant chemoradiotherapy in patients with esophageal squamous cell carcinomaYi-Lin Chang, Ya-Fu Cheng, Hui-Shan Chen, et al.
Lung Cancer (Amsterdam, Netherlands)|January 2, 2018
The predictive value of the interferon-γ release assay for chemotherapy responses in patients with advanced non-small-cell lung cancerHsu-Ching Huang, Wei-Juin Su, Chi-Lu Chiang, et al.
Plos One|June 26, 2025
Efficacy and safety of cisplatin + docetaxel + 5-FU + leucovorin + methotrexate and epirubicin combination chemotherapy for advanced esophageal cancerSung-Chi Yu, Shao-Syuan Tong, Yi-Ling Chen, et al.
Biomed Research International|July 2, 2014
Time sensitivity factor of single pulmonary nodule: a new cancer characteristic metabolic parameter by (18) F-FDG PETChing-Yuan Cheng, Kwo-Whei Lee, Chiang-Hsuan Lee, et al.
Oncology Reports|December 6, 2005
Aberrant promoter methylation of EDNRB in lung cancer in TaiwanShu-Chen Chen, Chia-Yu Lin, Ya-Hui Chen, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Cancer Chemotherapy and Pharmacology|February 5, 2013
Reply to: Clusterin inhibition to enhance tumor chemosensitivity in systemic tumorsChing-Yuan Cheng, Shur-Hueih Cherng, Wen-Jun Wu, et al.
Cancer Chemotherapy and Pharmacology|June 2, 2011
Regulation of chemosensitivity and migration by clusterin in non-small cell lung cancer cellsChing-Yuan Cheng, Shur-Hueih Cherng, Wen-Jun Wu, et al.
Biochemical Pharmacology|June 25, 2026
WISP-3 drives LUAD metastasis by suppressing miR-5004-5p to upregulate MMP-12Chia-Chia Chao, Chiang-Wen Lee, Syuan-Ling Lin, et al.
Scientific Reports|April 22, 2025
Comparison of outcome between sole operation and operation after tube thoracostomy in late phase empyemaShao-Syuan Tong, Yi-Ling Chen, Ya-Fu Cheng, et al.
Cancer Chemotherapy and Pharmacology|January 10, 2025
Endoglin as a predictive biomarker for pemetrexed sensitivity in non-small-cell lung cancer: a cellular studyChing-Yuan Cheng, Wen-Chen Chuang, Ching-Pin Lin, et al.
Plos One|October 13, 2022
Propensity score analysis comparing survival between definitive chemoradiotherapy and esophagectomy with adjuvant chemoradiotherapy in patients with esophageal squamous cell carcinomaYi-Lin Chang, Ya-Fu Cheng, Hui-Shan Chen, et al.
Lung Cancer (Amsterdam, Netherlands)|January 2, 2018
The predictive value of the interferon-γ release assay for chemotherapy responses in patients with advanced non-small-cell lung cancerHsu-Ching Huang, Wei-Juin Su, Chi-Lu Chiang, et al.
Plos One|June 26, 2025
Efficacy and safety of cisplatin + docetaxel + 5-FU + leucovorin + methotrexate and epirubicin combination chemotherapy for advanced esophageal cancerSung-Chi Yu, Shao-Syuan Tong, Yi-Ling Chen, et al.
Biomed Research International|July 2, 2014
Time sensitivity factor of single pulmonary nodule: a new cancer characteristic metabolic parameter by (18) F-FDG PETChing-Yuan Cheng, Kwo-Whei Lee, Chiang-Hsuan Lee, et al.
Oncology Reports|December 6, 2005
Aberrant promoter methylation of EDNRB in lung cancer in TaiwanShu-Chen Chen, Chia-Yu Lin, Ya-Hui Chen, et al.
Pageof 8